Additional file 1: Figure S1. Chinese vertical governmental and administrative model and the three-level hospitals in the CAMI registry. Figure S2. Flow-chart of patients included in this study. Figure S3. Reasons for No Reperfusion Therapy among the Eligible STEMI Patients. Figure S4. Landmark analysis of association of SMuRF status with all-cause mortality to 2 years. Table S1. Definition of study variables. Table S2. Baseline information stratified by the number of standard modifiable risk factors. Table S3. Adjusted Proportions of Evidence-based Medication Use among Patients with First ST-segment Elevation Myocardial Infarction by Number of Cardiovascular Risk Factors. Table S4. Association of SMuRF status with in-hospital, 30-day, and 2-year mortality. Table S5. Sensitivity analysis for the association of SMuRF status with all-cause mortality at 30 days.
Date made available | 2022 |
---|
Publisher | Figshare |
---|